LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 99 filers reported holding LYELL IMMUNOPHARMA INC in Q1 2023. The put-call ratio across all filers is 3.20 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $25 | -53.7% | 17,078 | 0.0% | 0.00% | – |
Q2 2023 | $54 | +28.6% | 17,078 | -4.6% | 0.00% | – |
Q1 2023 | $42 | -45.5% | 17,903 | -19.1% | 0.00% | -100.0% |
Q4 2022 | $77 | -100.0% | 22,128 | 0.0% | 0.00% | -50.0% |
Q3 2022 | $162,000 | +13.3% | 22,128 | +1.0% | 0.00% | +100.0% |
Q2 2022 | $143,000 | +28.8% | 21,912 | -0.2% | 0.00% | 0.0% |
Q1 2022 | $111,000 | – | 21,960 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 20,162,332 | $156,056,000 | 45.49% |
Foresite Capital Management IV, LLC | 13,282,181 | $102,804,000 | 21.15% |
Apoletto Ltd | 15,093,969 | $116,827,000 | 14.55% |
SB Management Ltd | 3,500,000 | $27,090,000 | 2.68% |
HSG Holding Ltd | 3,045,997 | $23,576,000 | 2.11% |
MIC Capital Management UK LLP | 1,320,000 | $10,217,000 | 1.95% |
Alphabet Inc. | 5,865,125 | $45,396,000 | 1.10% |
Board of Trustees of The Leland Stanford Junior University | 1,647,882 | $12,754,000 | 0.80% |
Adero Partners, LLC | 491,372 | $3,803,000 | 0.62% |
Ergoteles LLC | 1,008,428 | $7,805,000 | 0.30% |